dr.-reddy’s-gets-dcgi-approval-for-zytorvi-in-advanced-oesophageal-cancer News in Hindi -1 News Headlines Found

Dr. Reddy’s gets DCGI approval for Zytorvi in Advanced Oesophageal Cancer

Hyderabad, Oct 21 (UNI) Dr. Reddy’s Laboratories has received approval from the Drugs Controller General of India (DCGI) for Zytorvi (toripalimab), in combination with cisplatin and paclitaxel, for the first-line treatment of adults with unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma (ESCC).

#Dr. Reddy’s gets DCGI approval for Zytorvi in Advanced Oesophageal Cancer